• slide1
  • slider3
  • slide5
  • slide4
  • slide2

HRF, Inc. has been majority owned and operated by individuals with coagulation disorders since its inception in 1985. The owners are employees or partners with a lifetime of hemophilia care, coagulation clinical experience, plasmapheresis and/or collection experience. The company was founded with three basic mission principles:

  1. To insure that this much needed human plasma would meet the needs of the scientific research community as they strived to find a cure for hemophilia, or developed new clotting therapies;
  2. To provide a safe, clean and local center that would allow founding partners the opportunity to have their (rare) plasma marketed in an international market; and
  3. To assist donors (most with costly coagulation disorders) with the opportunity to participate in the financial end of the market for their (rare) plasma through this paid donation program

HRF, Inc. is a US Licensed, FDA Regulated Source Plasma Center and also provides Rare Human Blood Plasma for the International Market (non-injectable) for Manufacture into in vitro Diagnostic Products, Research and Development of Clotting Concentrates and Aid in the Search for a Cure for Hemophilia and Other Coagulation Disorders through Genetic Discovery.